FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: EU GMP

  • Home
  •  | 
  • Tag Archives: "EU GMP"

Rubicon Organics Commences EU-GMP Certification Process

Rubicon Organics Commences EU-GMP Certification Process
March 12, 2019 /CNW/ - Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics" or the "Company") a super-premium, organic cannabis producer with operations in Canada, Washington and California, is proud to announce that its 125,000 sq. ft. licensed facility in Delta, B.C. (the "BC Facility") has commenced preparation for its European Union - Good Manufacturing Practices ("EU-GMP") certification. 
Read more

Blissco Receives Positive EU GMP Inspection Report

Blissco Receives Positive EU GMP Inspection Report
March 07, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia, a licensed processor and producer of premium dried cannabis and cannabis oil, and a licensed distributor of dried cannabis products.
Read more

Aphria completes first shipment of cannabis oil to Argentina for clinical study on treating refractory epilepsy in children

Aphria completes first shipment of cannabis oil to Argentina for clinical study on treating refractory epilepsy in children
LEAMINGTON, ON, Oct. 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has completed its first shipment of cannabis oil to its Argentina-based subsidiary ABP, S.A. ("ABP" or the "Argentinean Company"), a pharmaceutical import and distribution company. In accordance with a previously announced supply agreement, the Company delivered 1,500 bottles of Aphria's renowned Rideau CBD oil, which were provided to Hospital de Pediatria Garrahan ("Hospital Garrahan" or the "Hospital"), a leading pediatric hospital located in Buenos Aires, for use in a clinical study focused on treating refractory epilepsy in children.
Read more